This study was designed to investigate predictive value of plasma C-type natriuretic peptide (CNP) in the therapeutic efficacy of metoprolol on postural tachycardia syndrome (POTS) in children. The gene discussed is CNP; the disease is postural orthostatic tachycardia syndrome.